Reproductive Health and Hormonal Regulation
Reproductive health is a vital component of overall human health, with its core lying in the functional balance of the reproductive system under hormonal regulation. Reproductive health and hormonal regulation represent a central function of the human endocrine system, involving key physiological processes such as gamete production, sex hormone balance, fertility maintenance, and sexual function regulation. These processes rely on the precise control of the hypothalamic-pituitary-gonadal (HPG) axis, encompassing core links such as ovulation induction, sex hormone replacement, fertility treatment, and sexual function modulation. Peptide-based drugs, characterized by high biological activity, strong target specificity, and good biocompatibility, have become important tools for intervening in reproductive endocrine disorders. They correct hormonal imbalances at the mechanistic level, providing innovative solutions for issues such as infertility, sex hormone deficiency, and sexual dysfunction.
Core Application Areas
1. Ovulation Induction: Reshaping Follicular Development and Ovulation Cycle
Ovulation induction is a key strategy for treating female anovulatory infertility. Peptide-based drugs precisely regulate follicular development by mimicking natural gonadotropin-releasing hormone (GnRH) or directly supplementing gonadotropins.
GnRH analog regulation
By modulating the activity of pituitary GnRH receptors, these drugs inhibit the premature occurrence of the endogenous luteinizing hormone (LH) surge, preventing premature follicular luteinization. This creates a stable hormonal environment for controlled ovarian hyperstimulation (COH) in assisted reproductive technology (ART), improving the efficiency of high-quality follicle recruitment.
Application of gonadotropin peptides
Human chorionic gonadotropin (hCG) mimics LH function to trigger ovulation in mature follicles; human menopausal gonadotropin (hMG), containing follicle-stimulating hormone (FSH) and LH activities, directly stimulates follicular growth and development, significantly enhancing the success rates of natural conception and ART.
Figure 1 Hormonal regulation of follicle growth and expulsion. Primordial follicles transition to primary stage via PI3K/AKT/mTOR signaling, then develop into sinus follicles through FSH and local regulators. Finally, LH triggers oocyte maturation and ovulation. Source: Frontiers in Medicine.
2. Sex Hormone Replacement: Rebuilding Endocrine Balance
For diseases related to sex hormone deficiency or imbalance, peptide-based drugs achieve physiological hormone replacement by regulating the HPG axis or directly supplementing hormone precursors.
GnRH pulse therapy
Indicated for patients with hypothalamic hypogonadism, this therapy involves periodic infusion of GnRH analogs to mimic physiological pulsatile secretion. This stimulates the pituitary to release FSH/LH, promoting gonadal development and sex hormone synthesis, and restoring pubertal development or fertility.
Testosterone and estrogen-regulating peptides
Some synthetic peptides enhance GnRH neuron activity, promoting pulsatile LH secretion to indirectly regulate testosterone/estrogen levels. This improves symptoms such as low libido and menstrual disorders caused by hypogonadism.
3. Fertility Treatment: Critical Support for Assisted Reproductive Technology
In the field of assisted reproduction, peptide-based drugs are used throughout the entire process—follicular development, oocyte retrieval, and luteal support—to enhance treatment safety and success rates.
Hyperstimulation phase
hMG combined with FSH peptide formulations precisely controls follicle recruitment, reducing the risk of ovarian hyperstimulation syndrome (OHSS); GnRH antagonists inhibit the early LH surge, preventing premature oocyte maturation or loss.
Oocyte retrieval and luteal phase:
hCG triggers final oocyte maturation, and postoperative supplementation with hCG or GnRH agonists maintains luteal function, improves endometrial receptivity, and enhances embryo implantation rates.
Male fertility intervention: Gonadotropin-releasing peptides regulate male LH/FSH secretion, promoting spermatogenesis and protecting fertility in idiopathic oligoasthenospermia.
4. Sexual Function Modulation: Bidirectional Intervention in Neuroendocrine Pathways
Sexual dysfunction (e.g., erectile dysfunction, decreased libido) is often associated with hormonal imbalance and abnormal neural signaling. Peptide-based drugs improve function through dual central and peripheral mechanisms.
Central excitatory peptides
Certain peptide products (e.g., Pt141) act as melanocortin receptor agonists, activating the hypothalamic-spinal pathway to enhance sexual arousal. They are particularly effective for vascular or psychogenic erectile dysfunction and are unaffected by food or alcohol.
Hormonal regulation and emotional association
Peptide products such as oxytocin promote the release of neurotransmitters related to intimate behavior, improving emotional disorders associated with sexual function. They also regulate uterine contractions and lactation, playing multiple roles in perinatal reproductive health; growth hormone-releasing peptides (e.g., ipamorelin) indirectly improve male libido and sexual performance by increasing testosterone levels.
The application of peptide-based drugs in reproductive health and hormonal regulation marks a shift from empirical treatment to mechanistic intervention. By precisely targeting the HPG axis, neuroendocrine pathways, and gonadal functions, these drugs demonstrate multidimensional advantages in ovulation induction, sex hormone replacement, fertility treatment, and sexual function modulation: they not only meet the high-precision requirements of assisted reproductive technology but also enable personalized regulation according to individual differences.